The litigation involves claims over how proceeds from the sale of Lion's Choice parent company were distributed among minority investors in 2013.
The sale traces back to Humana's 2021 acquisition strategy and comes as the insurer navigates rising medical costs and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results